Literature DB >> 7527331

Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex.

J Dai1, R C Baxter.   

Abstract

The acid-labile subunit (ALS) and insulin-like growth factor (IGF)-binding protein-3 are glycoproteins that form a complex carrying about 90% of the circulating IGFs. This study investigates the regulation of ALS expression by Northern hybridization, and serum ALS levels by RIA, in the rat. Northern analysis of ALS messenger RNA (mRNA) from adult rat brain, heart, lung, muscle, spleen, testis or ovary, kidney, and liver showed a liver-specific predominant 2-kilobase transcript. The steady state abundance of rat ALS mRNA was greatly reduced in neonatal and weanling liver compared to adult liver, with an age dependence similar to that of rat serum ALS levels. Fasting for 24 or 48 h decreased serum IGF-I and ALS levels, but not hepatic ALS mRNA. Streptozotocin-diabetic rats, untreated or treated with human GH for 5 days, had significantly decreased serum ALS levels and liver ALS mRNA abundance. Insulin treatment normalized serum ALS without fully restoring ALS mRNA. Dexamethasone, an inhibitor of ALS synthesis by hepatocytes, significantly reduced both serum ALS and hepatic ALS mRNA. The discrepancies between hepatic expression and serum ALS levels in fasting and diabetes point to a complex regulatory mechanism in which events at the translational level or later may be as important as regulation of gene expression or mRNA stability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527331     DOI: 10.1210/endo.135.6.7527331

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  The acid-labile subunit is required for full effects of exogenous growth hormone on growth and carbohydrate metabolism.

Authors:  Iori Ueki; Sarah L Giesy; Kevin J Harvatine; Jin Wook Kim; Yves R Boisclair
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

3.  Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH.

Authors:  F E Finamor; A M Lengyel
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

4.  Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system.

Authors:  I Ueki; G T Ooi; M L Tremblay; K R Hurst; L A Bach; Y R Boisclair
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex.

Authors:  Y R Boisclair; D Seto; S Hsieh; K R Hurst; G T Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression.

Authors:  Brenna M Flannery; Chidozie J Amuzie; James J Pestka
Journal:  Toxicology       Date:  2013-01-05       Impact factor: 4.221

7.  Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.

Authors:  C Matuschek; M Rudoy; M Peiper; P A Gerber; N P Hoff; B A Buhren; B Flehmig; W Budach; W T Knoefel; H Bojar; H B Prisack; G Steinbach; V Shukla; A Schwarz; K Kammers; A Erhardt; A Scherer; E Bölke; M Schauer
Journal:  Eur J Med Res       Date:  2011-10-10       Impact factor: 2.175

8.  Evaluation of IGF-I levels and serum protein profiles of diabetic cats and dogs.

Authors:  Gulay Ciftci; Gul Fatma Yarim
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

Review 9.  Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.

Authors:  Kristina M Mueller; Madeleine Themanns; Katrin Friedbichler; Jan-Wilhelm Kornfeld; Harald Esterbauer; Jan P Tuckermann; Richard Moriggl
Journal:  Mol Cell Endocrinol       Date:  2012-04-30       Impact factor: 4.102

10.  Pathological impact of SMN2 mis-splicing in adult SMA mice.

Authors:  Kentaro Sahashi; Karen K Y Ling; Yimin Hua; John Erby Wilkinson; Tomoki Nomakuchi; Frank Rigo; Gene Hung; David Xu; Ya-Ping Jiang; Richard Z Lin; Chien-Ping Ko; C Frank Bennett; Adrian R Krainer
Journal:  EMBO Mol Med       Date:  2013-09-09       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.